Clin2
NCT07449741Possibly a fitRecruiting

Early safety test of HXN6005 in healthy adults

Healthy Volunteers (HV)

This early-phase study tests an experimental drug called HXN6005 in healthy adults to see how safe it is and how the body handles it. It's looking for volunteers who are generally healthy and meet basic age and weight requirements.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
32 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old.
  • You are generally healthy (no diabetes, cancer history, or serious infections like HIV or hepatitis).
  • You have a body mass index (BMI) between 18 and 35 – that's a healthy weight range.
  • You are willing to use effective birth control if needed and avoid pregnancy or donating sperm/eggs for about 6 months after the study.
  • You haven't taken any prescription or over-the-counter medications, herbal supplements, or vaccines in the past week (or longer for some).
  • You haven't participated in another clinical trial or donated blood in the last month.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07735728Not yet recruiting· Phase 1
Testing ZE66-0205 in healthy volunteers

This study is testing a new medicine called ZE66-0205 for the first time in people. It is looking at healthy volunteers to see how the drug is processed by the body and if it is safe.

Randwick, New South Wales
NCT07580794Recruiting· Phase 1
Safety Study of New Drug HSK56630 in Healthy People

This is an early-stage safety test of a new investigational drug called HSK56630 in healthy volunteers with no major medical conditions. Researchers will monitor how your body tolerates the drug and what side effects might occur.

Bayswater, Victoria
NCT07757659Not yet recruiting· Phase 1
Study of a new drug in healthy adults

This trial studies a new drug called XKH001 in healthy volunteers. It is a single-dose study to see how the drug is processed by the body and to check for safety and tolerability.

Melbourne
NCT07549750Not yet recruiting· Phase 1
Safety Study of HXN5003 in Healthy Adults

This is an early-stage safety study testing a new experimental drug called HXN5003 in healthy volunteers. Researchers will give increasing doses to see how safe the drug is and how the body handles it.

Bayswater, Victoria
NCT07262281Recruiting· Phase 1
Safety study of HY6725 in healthy adults

This trial tests a new drug called HY6725 in healthy volunteers to see if it is safe and how the body processes it. It may help pave the way for future treatments.

Melbourne
NCT06999720Recruiting· Phase 1
Study of an experimental drug in healthy volunteers

This trial is testing a new drug called HX15001 in healthy adults to see how safe it is and how the body processes it. It may help researchers decide if the drug can be tested in people with a specific condition in the future.

Herston, Queensland

Hear when a new Healthy Volunteers (HV) trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.